DDA Notice Regarding Distribution of Tocilizumab Injection (Actemra) 400mg/20 ml

Important information regarding Distribution of Tocilizumab Injection (Actemra) 400mg/20 ml

Criteria prescribed by the Government of Nepal for the patients of Covid-19 at Covid Hospital As per the import recommendation provided by the Department of Drug Administration – DDA Today on 2078/02/14 Yetichem Distributor Pvt. Ltd, Kathmandu Tocilizumab injection (Actemra) 400mg / 20ml, 500 vials are imported as follows: As there is an arrangement to provide only to the targeted patients, all concerned are informed.

The person going to get the medicine will have to submit the following documents

In the letter of recommendation of the hospital where the patient was admitted, the official of Covid-19 Hospital Physician’s Name, NMC NO., Phone number with signature
Patient’s prescription
Corona PCR test positive report
Phone number of relatives who come to buy medicine. And identity card with photo

The patient has been admitted by the official doctor of Covid-19 Hospital. The name of the hospital, the name of the patient, the quantity of the recommended medicine and the name of the relative of the patient to whom the medicine is understood are also disclosed. Mandatory SMS to mobile number 9851020960 should be sent to the importer
For any patient, the doctor prescribes only one vial at a time and at most one patient Recommendation can be made only up to two times
The Government of Nepal, Ministry of Health and Population and Nepal Medicine while recommending the drug the Covid-19 treatment protocol issued by the council must be followed
Importers will make available to the patients outside Kathmandu through ambassador medium as soon as possible Will have to make arrangements
The drug cost the patient. A. 59,850 / – per vial will be available.